AltaValve System Shows Promise for Severe Mitral Regurgitation in 1-Year Results

(MedPage Today) — The AltaValve transcatheter mitral valve replacement (TMVR) system had sustained effects among patients with severe mitral regurgitation out to 1 year, according to an early feasibility study (EFS).
Among 30 participants with…